artificial intelligence

Time Optimisation in Radiation Therapy Planning: Insights from UK Surveys
Recently published data give a glimpse on the time spent for treatment preparation in UK radiation oncology centres. As expected,organ-at-risk and target contouring contouring is…
MVision AI receives TGA approval and market authorization for Australia
HELSINKI, Finland – May 1, 2024 An application for MVision AI Segmentation (Contour+) has been submitted and accepted by the Therapeutic Goods Administration (TGA) under…
New proofs supporting the efficacy of radiation therapy for kidney cancer 
February is the month when Cancer research UK raises awareness about kidney cancer. In 2020 over 400 000 people were diagnosed with this disease, and…
World Cancer Day – Joining efforts for a better cancer care
World cancer day, celebrated on the 4th of February, was established more than 20 years ago. It represents an initiative of the Union for International…
The world’s first comprehensive GBS™ solution for radiation therapy cancer treatment is now available for implementation in Canadian clinics
HELSINKI, Finland – January 22, 2024 MVision AI announces first Health Canada Medical Device License for MVision AI Segmentation (Contour+).  In conjunction with Guide and…
Merging (Artificial) Intelligence and Ethics in Radiation Oncology – Why and How?
”Our future is a race between the growing power of technology and the wisdom with which we use it.” This statement of Stephen Hawking, the…
Man vs. Machine (Learning): Comparing Speed and Cost-Effectiveness of Manual vs. Deep Learning Segmentation-Aided Volume Delineation for Head and Neck Lymph Node Targets
This preliminary study shows that using an AI-based segmentation-aided approach to Head and Neck Lymph Node stations can be feasibly implemented within a standard Radiation…
Clinical User Experience with MVision AI
This is a webinar that you don’t want to miss! You’ll hear from an actual user and their clinical experience with MVision’s AI-powered software. Please…
Advancements in Breast Cancer Treatment: Highlights from the ESTRO 2023 Conference
The annual meeting of the European Society for Radiotherapy and Oncology (ESTRO) took place in Vienna from 12 to 15 May, gathering over 6000 professionals.…
Radiotherapy for Esophageal Cancer – The Challenge of a Difficult Site
More than half a million people are diagnosed each year with esophageal cancer. It is the 8th most common cancer type and places sixth regarding…